Search results
Results From The WOW.Com Content Network
Hydromorphone, also known as dihydromorphinone, and sold under the brand name Dilaudid among others, is a morphinan opioid used to treat moderate to severe pain. [7] Typically, long-term use is only recommended for pain due to cancer . [ 9 ]
In medicine, specifically in end-of-life care, palliative sedation (also known as terminal sedation, continuous deep sedation, or sedation for intractable distress of a dying patient) is the palliative practice of relieving distress in a terminally ill person in the last hours or days of a dying person's life, usually by means of a continuous intravenous or subcutaneous infusion of a sedative ...
Acute use (1–3 days) yields a potency about 1.5× stronger than that of morphine and chronic use (7 days+) yields a potency about 2.5 to 5× that of morphine. Similarly, the effect of tramadol increases after consecutive dosing due to the accumulation of its active metabolite and an increase of the oral bioavailability in chronic use.
Morphinone itself is an active opioid, though its potency is closer to codeine than morphine. [citation needed] It is, however, an important precursor and would fall under the purview of the Controlled Substances Act within the United States.
SQ subcutaneously "SQ" can be mistaken for "5Q" meaning "5 every dose". See also SC: SSRI selective serotonin reuptake inhibitor [or] sliding scale regular insulin: ambiguous. Do not abbreviate st. stet: let it stand (for example, for settling) stat : statim: immediately SubQ., subcut subcutaneously sum. sumat [or] sumendum: let him take [or]
Premedication before chemotherapy for cancer often consists of drug regimens (usually 2 or more drugs, e.g. dexamethasone, diphenhydramine and omeprazole) given to a patient minutes to hours before the chemotherapy to avert side effects or hypersensitivity reactions (i.e. allergic reactions). [citation needed]
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
Dihydromorphine acts as an agonist at the μ-opioid with a K i value of 2.5 nM compared to 4.9 nM of morphine, δ-opioid with a K i value of 137 nM compared to 273 nM of morphine and κ-opioid with a K i value of 223 nM compared to 227 nM of morphine. Dihydromorphine is therefore slightly more μ-selective than morphine.